RAB27B antisense RNA 1 (RAB27B-AS1)

RAB27B antisense RNA 1 (RAB27B-AS1) is predicted to be a long non-coding RNA (lncRNA) transcribed on the antisense strand of the RAB27B locus. As of 2024, there is no direct experimental evidence characterizing its biological function, disease association, or relevance as a therapeutic target in humans. RAB27B-AS1 is not listed as a protein-coding gene and is not known to encode a receptor, enzyme, transporter, or signaling protein. No publications or biochemical studies confirm regulatory or functional activity for RAB27B-AS1, nor is it implicated in drug action, biomarker development, or safety concerns. There is frequent confusion between protein-coding RAB27B (a small GTPase, which has been implicated in cancer and vesicular trafficking) and its predicted or annotated antisense lncRNA transcript "RAB27B-AS1". Only RAB27B, not RAB27B-AS1, is considered a validated therapeutic target or biomarker in current biomedical literature. No evidence supports clinical or therapeutic relevance for RAB27B-AS1 as of the current knowledge base. RAB27B-AS1 is a predicted non-coding antisense RNA and not a validated therapeutic target. There is no experimental or clinical data supporting a functional or disease-related role for RAB27B-AS1. The major target of interest in the RAB27B locus is the protein-coding gene RAB27B, not its antisense transcript.

Other names

LncRNA RAB27B-AS1long non-coding RNA RAB27B-AS1

Not applicable